Beijing Bohui Innovation Technology Co Ltd (300318) - Total Assets
Based on the latest financial reports, Beijing Bohui Innovation Technology Co Ltd (300318) holds total assets worth CN¥4.33 Billion CNY (≈ $632.97 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 300318 net assets for net asset value and shareholders' equity analysis.
Beijing Bohui Innovation Technology Co Ltd - Total Assets Trend (2004–2024)
This chart illustrates how Beijing Bohui Innovation Technology Co Ltd's total assets have evolved over time, based on quarterly financial data.
Beijing Bohui Innovation Technology Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Beijing Bohui Innovation Technology Co Ltd's total assets of CN¥4.33 Billion consist of 29.7% current assets and 70.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 1.9% |
| Accounts Receivable | CN¥113.01 Million | 2.7% |
| Inventory | CN¥1.01 Billion | 24.5% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥411.63 Million | 10.0% |
| Goodwill | CN¥786.27 Million | 19.1% |
Asset Composition Trend (2004–2024)
This chart illustrates how Beijing Bohui Innovation Technology Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Beijing Bohui Innovation Technology Co L market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Beijing Bohui Innovation Technology Co Ltd's current assets represent 29.7% of total assets in 2024, a decrease from 97.7% in 2004.
- Cash Position: Cash and equivalents constituted 1.9% of total assets in 2024, down from 59.3% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 28.0% of total assets, an increase from 0.0% in 2004.
- Asset Diversification: The largest asset category is inventory at 24.5% of total assets.
Beijing Bohui Innovation Technology Co Ltd Competitors by Total Assets
Key competitors of Beijing Bohui Innovation Technology Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fortress Biotech Inc
NASDAQ:FBIO
|
USA | $185.55 Million |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $261.73 Million |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
USA | $1.08 Billion |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
BrightGene Bio Medical Technology C
SHG:688166
|
China | CN¥5.38 Billion |
|
BioArctic AB (publ)
ST:BIOA-B
|
Sweden | Skr2.60 Billion |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Beijing Bohui Innovation Technology Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.03 | 1.26 | 0.54 |
| Quick Ratio | 0.22 | 0.28 | 0.15 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥38.71 Million | CN¥259.98 Million | CN¥-913.91 Million |
Beijing Bohui Innovation Technology Co Ltd - Advanced Valuation Insights
This section examines the relationship between Beijing Bohui Innovation Technology Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.79 |
| Latest Market Cap to Assets Ratio | 0.16 |
| Asset Growth Rate (YoY) | 5.1% |
| Total Assets | CN¥4.13 Billion |
| Market Capitalization | $669.41 Million USD |
Valuation Analysis
Below Book Valuation: The market values Beijing Bohui Innovation Technology Co Ltd's assets below their book value (0.16x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Beijing Bohui Innovation Technology Co Ltd's assets grew by 5.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Beijing Bohui Innovation Technology Co Ltd (2004–2024)
The table below shows the annual total assets of Beijing Bohui Innovation Technology Co Ltd from 2004 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥4.13 Billion ≈ $603.70 Million |
+5.08% |
| 2023-12-31 | CN¥3.93 Billion ≈ $574.50 Million |
+0.46% |
| 2022-12-31 | CN¥3.91 Billion ≈ $571.86 Million |
+5.91% |
| 2021-12-31 | CN¥3.69 Billion ≈ $539.97 Million |
-0.68% |
| 2020-12-31 | CN¥3.72 Billion ≈ $543.66 Million |
+37.88% |
| 2019-12-31 | CN¥2.69 Billion ≈ $394.31 Million |
-0.65% |
| 2018-12-31 | CN¥2.71 Billion ≈ $396.90 Million |
-0.92% |
| 2017-12-31 | CN¥2.74 Billion ≈ $400.58 Million |
+30.71% |
| 2016-12-31 | CN¥2.09 Billion ≈ $306.46 Million |
+1.16% |
| 2015-12-31 | CN¥2.07 Billion ≈ $302.93 Million |
+158.99% |
| 2014-12-31 | CN¥799.34 Million ≈ $116.97 Million |
+6.24% |
| 2013-12-31 | CN¥752.40 Million ≈ $110.10 Million |
+7.30% |
| 2012-12-31 | CN¥701.23 Million ≈ $102.61 Million |
+167.95% |
| 2011-12-31 | CN¥261.70 Million ≈ $38.29 Million |
+21.90% |
| 2010-12-31 | CN¥214.68 Million ≈ $31.41 Million |
+20.68% |
| 2009-12-31 | CN¥177.90 Million ≈ $26.03 Million |
+22.35% |
| 2008-12-31 | CN¥145.40 Million ≈ $21.28 Million |
+37.17% |
| 2007-12-31 | CN¥106.00 Million ≈ $15.51 Million |
+31.62% |
| 2006-12-31 | CN¥80.53 Million ≈ $11.78 Million |
+5.79% |
| 2005-12-31 | CN¥76.12 Million ≈ $11.14 Million |
+31.94% |
| 2004-12-31 | CN¥57.70 Million ≈ $8.44 Million |
-- |
About Beijing Bohui Innovation Technology Co Ltd
Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; albumin; human prothrombin complex; and vaccine for rabies. It also provides molecular platform, such as Automatic Real-time Fl… Read more